Business Context and Reporting Period
Company: CareCloud, Inc. (CCLD)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: CareCloud is a healthcare information technology company providing technology-enabled revenue cycle management (RCM), cloud-based software (EHR, Practice Management), and professional services to healthcare providers. The company operates two segments: Healthcare IT and Medical Practice Management. It leverages a significant offshore workforce in Pakistan and Sri Lanka to maintain cost advantages.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Net Revenue | $110.8 million | $117.1 million |
| GAAP Net Income (Loss) | $7.9 million | $(48.7) million |
| Adjusted EBITDA | $24.1 million | $15.4 million |
| Operating Cash Flow | $20.6 million | $15.5 million |
| Cash and Equivalents (Year-End) | $5.1 million | $3.3 million |
| Working Capital | $5.2 million | $(0.1) million |
| Total Liabilities | $21.8 million | $36.1 million |
| Debt Outstanding | $0.3 million (Notes Payable) | $10.3 million (Line of Credit + Notes) |
Note: The company reported a GAAP net loss attributable to common shareholders of $(4.5) million in 2024 due to preferred stock dividends, despite positive GAAP net income.
Material Changes vs. Prior Period
- Revenue Decline: Net revenue decreased 5% to $110.8 million. This was primarily driven by a $4.8 million decrease in project-based professional services and the loss of two large acquired accounts (approx. $2.8 million impact) that transitioned to their acquirers' systems.
- Profitability Improvement: GAAP net income swung from a loss of $48.7 million in 2023 to a profit of $7.9 million in 2024. The 2023 loss was heavily impacted by a $42 million non-cash goodwill impairment charge, which did not recur in 2024.
- Expense Reduction: Total operating expenses decreased 38% to $101.7 million. Direct operating costs fell 14% due to favorable foreign exchange rates (Pakistan) and headcount reductions. Selling and marketing expenses dropped 35% due to reduced spending and headcount.
- Debt Repayment: The company fully repaid its $10 million revolving line of credit with Silicon Valley Bank (SVB) during 2024, resulting in zero borrowings under the facility at year-end.
Guidance, Outlook, and Risks
Management Commentary & Strategy: Management is focused on reducing costs, maintaining profitability, and generating positive free cash flow to service preferred stock dividends. The strategy includes leveraging offshore operations for cost advantages, expanding AI capabilities (CareCloud cirrusAI), and driving organic growth through up-selling to existing clients.
Subsequent Events (Post-2024):
- Preferred Stock Conversion: In March 2025, the majority of Series A Preferred Stock was converted into common stock. Approximately 985,000 shares of Series A remained outstanding.
- Dividend Resumption: Dividends on Series A and Series B Preferred Stock, which were suspended in December 2023, resumed in February 2025.
- Delisting: The Series A Preferred Stock is being delisted from the Nasdaq Global Market.
Key Risks & Contingencies:
- Offshore Operations: Significant reliance on operations in Pakistan and Sri Lanka exposes the company to political instability, currency fluctuations, and regulatory changes.
- Liquidity & Dividends: The ability to pay preferred dividends is contingent on compliance with SVB loan covenants (Adjusted EBITDA or liquidity ratios) and sufficient cash flow. Dividends were suspended for 14 months in 2023-2024.
- Goodwill Impairment: While no impairment occurred in 2024, the company notes that goodwill remains subject to future impairment if performance metrics or stock prices decline.
- Customer Concentration: One customer accounted for approximately 10% of total revenue in 2024.
Investor Verification Checklist
- Dividend Sustainability: Verify the company's ability to maintain preferred dividend payments given the recent resumption and the requirement to meet SVB covenants.
- Revenue Quality: Assess the impact of the loss of the two large acquired accounts and whether the decline in professional services revenue is a temporary or structural trend.
- Offshore Exposure: Review the specific risks associated with the Pakistan and Sri Lanka operations, including currency exchange rate impacts on margins.
- Debt Covenants: Confirm current compliance with the SVB credit agreement, specifically the Adjusted EBITDA and liquidity ratio requirements.
- Capital Structure: Understand the dilution effects of the March 2025 Series A Preferred Stock conversion on common shareholders.